In HCS Pharma we strongly believe that 3D cell culture is the right way to improve drug dicovery processes. Moreover, we know that our 3D HydroscaffoldTM matrix BIOMIMESYS® could be useful for bioproduction. We will be happy Read more…
This is the end of Rania‘s 6-month internship in HCS Pharma about a new liver biochip system. After a first publication “Development of Liver-on-Chip Integrating a Hydroscaffold Mimicking the Liver’s Extracellular Matrix” in collaboration with Read more…
BIOMIMESYS® has taken place in the panel of the future medicine on the 27th of September. The next step has arrived, and Nathalie Maubon CEO of HCS Pharma has taken BIOMIMESYS® all the way to Read more…
1 Comment
HCS Pharma @BioAsia Taiwan 2023 - HCS Pharma · July 26, 2023 at 12:13 pm
[…] more information about this Focus symposium, please find the detailed programme here. The symposium will be held in Room 403, Nangang International Exhibition Center, Hall1 (TaiNEX 1) […]